UBS Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.23M | Sell |
308,527
-864,561
| -74% | -$11.8M | ﹤0.01% | 3198 |
|
|
2025
Q1 | $13M | Buy |
1,173,088
+250,390
| +27% | +$2.77M | ﹤0.01% | 2147 |
|
|
2024
Q4 | $9.83M | Buy |
922,698
+876,923
| +1,916% | +$9.34M | ﹤0.01% | 2352 |
|
|
2024
Q3 | $581K | Buy |
45,775
+33,888
| +285% | +$430K | ﹤0.01% | 3985 |
|
|
2024
Q2 | $199K | Sell |
11,887
-30,980
| -72% | -$520K | ﹤0.01% | 4546 |
|
|
2024
Q1 | $643K | Buy |
42,867
+17,798
| +71% | +$267K | ﹤0.01% | 3903 |
|
|
2023
Q4 | $376K | Buy |
25,069
+5,850
| +30% | +$87.8K | ﹤0.01% | 4175 |
|
|
2023
Q3 | $269K | Buy |
19,219
+5,111
| +36% | +$71.6K | ﹤0.01% | 4063 |
|
|
2023
Q2 | $146K | Buy |
+14,108
| New | +$146K | ﹤0.01% | 4666 |
|
|
2023
Q1 | – | Sell |
-22,675
| Closed | -$201K | – | 9044 |
|
|
2022
Q4 | $201K | Sell |
22,675
-20,914
| -48% | -$186K | ﹤0.01% | 4362 |
|
|
2022
Q3 | $363K | Buy |
43,589
+17,719
| +68% | +$148K | ﹤0.01% | 3625 |
|
|
2022
Q2 | $212K | Sell |
25,870
-28,461
| -52% | -$233K | ﹤0.01% | 3893 |
|
|
2022
Q1 | $473K | Buy |
54,331
+6,675
| +14% | +$58.1K | ﹤0.01% | 3801 |
|
|
2021
Q4 | $453K | Buy |
47,656
+46,345
| +3,535% | +$441K | ﹤0.01% | 4052 |
|
|
2021
Q3 | $22K | Buy |
1,311
+411
| +46% | +$6.9K | ﹤0.01% | 5938 |
|
|
2021
Q2 | $14K | Sell |
900
-6,622
| -88% | -$103K | ﹤0.01% | 6619 |
|
|
2021
Q1 | $147K | Sell |
7,522
-4,404
| -37% | -$86.1K | ﹤0.01% | 4703 |
|
|
2020
Q4 | $215K | Buy |
11,926
+9,385
| +369% | +$169K | ﹤0.01% | 4238 |
|
|
2020
Q3 | $49K | Sell |
2,541
-6,560
| -72% | -$127K | ﹤0.01% | 4818 |
|
|
2020
Q2 | $237K | Sell |
9,101
-2,359
| -21% | -$61.4K | ﹤0.01% | 3889 |
|
|
2020
Q1 | $204K | Sell |
11,460
-10,400
| -48% | -$185K | ﹤0.01% | 3883 |
|
|
2019
Q4 | $730K | Buy |
21,860
+7,866
| +56% | +$263K | ﹤0.01% | 3599 |
|
|
2019
Q3 | $334K | Buy |
13,994
+10,535
| +305% | +$251K | ﹤0.01% | 4007 |
|
|
2019
Q2 | $124K | Buy |
3,459
+709
| +26% | +$25.4K | ﹤0.01% | 4406 |
|
|
2019
Q1 | $102K | Sell |
2,750
-1,573
| -36% | -$58.3K | ﹤0.01% | 4277 |
|
|
2018
Q4 | $186K | Buy |
4,323
+1,073
| +33% | +$46.2K | ﹤0.01% | 4163 |
|
|
2018
Q3 | $154K | Sell |
3,250
-2,208
| -40% | -$105K | ﹤0.01% | 4401 |
|
|
2018
Q2 | $272K | Buy |
5,458
+1,847
| +51% | +$92K | ﹤0.01% | 3919 |
|
|
2018
Q1 | $180K | Buy |
3,611
+865
| +32% | +$43.1K | ﹤0.01% | 4047 |
|
|
2017
Q4 | $102K | Buy |
2,746
+1,746
| +175% | +$64.9K | ﹤0.01% | 4405 |
|
|
2017
Q3 | $32K | Buy |
1,000
+627
| +168% | +$20.1K | ﹤0.01% | 5221 |
|
|
2017
Q2 | $7K | Buy |
+373
| New | +$7K | ﹤0.01% | 6041 |
|